3 Dirt Cheap Healthcare Shares Under $30 to Buy Right Now
Quick Read Pfizer’s 7% yield and forward P/E of 8 complement Viatris’s three FDA PDUFA decisions arriving before…
Implementing organic two-way interactions: How industry leaders in APAC aim to bolster messaging-led engagement
As consumer expectations continue to evolve across Asia-Pacific, one shift is becoming impossible for marketers to ignore: messaging…
Consumer healthcare mega merger: Kimberly-Clark to acquire Tylenol maker Kenvue in $48.7 billion cash and stock deal; $1.9 billion cost savings targeted post-merger
Kimberly-Clark is set to acquire Tylenol maker Kenvue in a cash-and-stock transaction valued at approximately $48.7 billion, creating…
Kimberly-Clark to buy Tylenol maker Kenvue in massive consumer merger
Caroline Woods: Big brands and big money – Kimberly-Clark is buying Kenvue in a nearly $50 billion cash…